Rechercher

Concours IRSC Projet Printemps 2021

Amélie Marsot
20 déc. 2022
1 min de lecture

PipEracillin-Tazobactam versus mERoPENem for treatment of bloodstream infections caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) – 371 024$ CAD

Principal Investigators: Lee TC, McDonald EG, Cheng MP

Co-candidates: Afra K, Bitterman R, Butler-Laporte G, Carignan A, Conly J, Grant J, Gregson D, Haljian G, Marsot A, Parkes L, Paul M, Somayaji R, Thirion D

Posts récents

Voir tout

Soutenance de Thèse - Alexandre Duong

Publication dans Expert Review of Clinical Pharmacology

Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development. El-Haffaf I, Williamson D, Nguyen VD, Duong A, Wi

Publication dans Clinical Pharmacokinetics

Guidance for External Evaluation and Selection of Population Pharmacokinetic Models for Precision Dosing. El Hassani M, Marsot A. Clin Pharmacokinet. 2026 Jan;65(1):1-9. doi: 10.1007/s40262-025-01602-

Commentaires